Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase 3 trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC).
mFOLFIRINOX;Gemcitabine
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase 3 trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC). ### Output: mFOLFIRINOX;Gemcitabine